Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/JOHNSON-JOHNSON-4832/news/Janssen-Announces-New-Data-Supporting-Safety-and-Efficacy-of-RYBREVANT-and-Lazertinib-Combination-fo-41101919/?utm_source=whatsapp&utm_medium=social&utm_campaign=share